Study of Unani formulation in decrease thyroid function.

Effect of Majoon-e-Falasafa and Safoof-e-Aqarqarha in Hypothyroidism - A Randomized Controlled Clinical study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011768

Enrollment

Registered

2018-02-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hypothyroidism

Interventions

Intervention1: Majoon-e-Falasafa and Safoof-e-Aqarqarha: 10gm/day of Majoon-e-Falasafa in two divided doses for 45 days 3.2 gm of Safoof-e-Aqarqarha in two divided

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of hypothyroidism Patient having the TSH range between 5.5-15mU/L.[2] Free T4 and T3 in normal reference range (Free T4: 0.9-2ng/dl and T3: 80-220ng/dl[1] ) Patient between the age of 20-60 years Either gender (male & female)

Exclusion criteria

Exclusion criteria: Pregnancy and lactating women Patients age below 20 and above 60 year All complicated case of Hypothyroidism including primary and secondary hypothyroidism Patient with H/o metabolic disorders and other systemic illness Recent thyroid surgery or radio-iodine intake Patient unable to give consent and who fail to follow-up

Design outcomes

Primary

Measure	Time frame
Thyroid Stimulating Hormone(TSH) Free T4 and T3 estimation Timepoint: Before and after treatment	—

Secondary

Measure	Time frame
Tiredness Cold intolerance Constipation Weight gain Loss of hair Timepoint: Before treatment, 15th day, 30th day and after treatment	—

Countries

India

Contacts

Public ContactDr Abdul Mobeen

National Institute of Unani Medicine

dr.mobeen@rediffmail.com8123143721

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026